nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—Tamoxifen—pancreatic cancer	0.265	0.335	CbGbCtD
Pentobarbital—CYP2A6—Fluorouracil—pancreatic cancer	0.195	0.247	CbGbCtD
Pentobarbital—CYP2C19—Tamoxifen—pancreatic cancer	0.11	0.139	CbGbCtD
Pentobarbital—CYP3A4—Tamoxifen—pancreatic cancer	0.0529	0.067	CbGbCtD
Pentobarbital—CYP3A4—Erlotinib—pancreatic cancer	0.045	0.057	CbGbCtD
Pentobarbital—CYP3A4—Irinotecan—pancreatic cancer	0.0406	0.0515	CbGbCtD
Pentobarbital—CYP3A4—Docetaxel—pancreatic cancer	0.0298	0.0377	CbGbCtD
Pentobarbital—CYP3A4—Sunitinib—pancreatic cancer	0.0297	0.0375	CbGbCtD
Pentobarbital—CYP3A4—Doxorubicin—pancreatic cancer	0.0222	0.0281	CbGbCtD
Pentobarbital—Liver injury—Tamoxifen—pancreatic cancer	0.00689	0.0328	CcSEcCtD
Pentobarbital—Hypoxia—Gemcitabine—pancreatic cancer	0.00627	0.0298	CcSEcCtD
Pentobarbital—Hepatocellular injury—Tamoxifen—pancreatic cancer	0.0058	0.0276	CcSEcCtD
Pentobarbital—Hepatocellular injury—Erlotinib—pancreatic cancer	0.00574	0.0273	CcSEcCtD
Pentobarbital—Respiratory failure—Sunitinib—pancreatic cancer	0.00506	0.024	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Sunitinib—pancreatic cancer	0.00479	0.0228	CcSEcCtD
Pentobarbital—Respiratory failure—Gemcitabine—pancreatic cancer	0.00406	0.0193	CcSEcCtD
Pentobarbital—Injection site reaction—Gemcitabine—pancreatic cancer	0.00396	0.0188	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00315	0.015	CcSEcCtD
Pentobarbital—Respiratory failure—Docetaxel—pancreatic cancer	0.00288	0.0137	CcSEcCtD
Pentobarbital—Hepatocellular injury—Docetaxel—pancreatic cancer	0.00283	0.0134	CcSEcCtD
Pentobarbital—Injection site reaction—Docetaxel—pancreatic cancer	0.00281	0.0134	CcSEcCtD
Pentobarbital—Ataxia—Fluorouracil—pancreatic cancer	0.00267	0.0127	CcSEcCtD
Pentobarbital—Bradycardia—Sunitinib—pancreatic cancer	0.00254	0.0121	CcSEcCtD
Pentobarbital—Angioedema—Tamoxifen—pancreatic cancer	0.00232	0.011	CcSEcCtD
Pentobarbital—Liver injury—Epirubicin—pancreatic cancer	0.00227	0.0108	CcSEcCtD
Pentobarbital—Syncope—Erlotinib—pancreatic cancer	0.00225	0.0107	CcSEcCtD
Pentobarbital—Loss of consciousness—Erlotinib—pancreatic cancer	0.0022	0.0105	CcSEcCtD
Pentobarbital—Anxiety—Tamoxifen—pancreatic cancer	0.00215	0.0102	CcSEcCtD
Pentobarbital—Anxiety—Erlotinib—pancreatic cancer	0.00213	0.0101	CcSEcCtD
Pentobarbital—Liver injury—Doxorubicin—pancreatic cancer	0.0021	0.00997	CcSEcCtD
Pentobarbital—Bradycardia—Irinotecan—pancreatic cancer	0.00209	0.00994	CcSEcCtD
Pentobarbital—Shock—Erlotinib—pancreatic cancer	0.00201	0.00957	CcSEcCtD
Pentobarbital—Angioedema—Sunitinib—pancreatic cancer	0.00198	0.00943	CcSEcCtD
Pentobarbital—Ataxia—Docetaxel—pancreatic cancer	0.00193	0.00918	CcSEcCtD
Pentobarbital—Hepatocellular injury—Epirubicin—pancreatic cancer	0.00191	0.00907	CcSEcCtD
Pentobarbital—Injection site reaction—Epirubicin—pancreatic cancer	0.0019	0.00902	CcSEcCtD
Pentobarbital—Constipation—Tamoxifen—pancreatic cancer	0.00177	0.00841	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.00176	0.00839	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—pancreatic cancer	0.00175	0.00834	CcSEcCtD
Pentobarbital—Constipation—Erlotinib—pancreatic cancer	0.00175	0.00832	CcSEcCtD
Pentobarbital—Shock—Sunitinib—pancreatic cancer	0.00174	0.00829	CcSEcCtD
Pentobarbital—Body temperature increased—Erlotinib—pancreatic cancer	0.00162	0.00769	CcSEcCtD
Pentobarbital—Syncope—Irinotecan—pancreatic cancer	0.0016	0.00762	CcSEcCtD
Pentobarbital—Loss of consciousness—Irinotecan—pancreatic cancer	0.00157	0.00747	CcSEcCtD
Pentobarbital—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00152	0.00725	CcSEcCtD
Pentobarbital—Constipation—Sunitinib—pancreatic cancer	0.00151	0.0072	CcSEcCtD
Pentobarbital—Confusional state—Irinotecan—pancreatic cancer	0.00147	0.007	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00147	0.00698	CcSEcCtD
Pentobarbital—Shock—Irinotecan—pancreatic cancer	0.00144	0.00683	CcSEcCtD
Pentobarbital—Confusional state—Fluorouracil—pancreatic cancer	0.00141	0.0067	CcSEcCtD
Pentobarbital—Body temperature increased—Sunitinib—pancreatic cancer	0.0014	0.00666	CcSEcCtD
Pentobarbital—Dizziness—Tamoxifen—pancreatic cancer	0.00137	0.0065	CcSEcCtD
Pentobarbital—Hypotension—Irinotecan—pancreatic cancer	0.00136	0.00648	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00136	0.00646	CcSEcCtD
Pentobarbital—Dizziness—Erlotinib—pancreatic cancer	0.00135	0.00643	CcSEcCtD
Pentobarbital—Hypotension—Gemcitabine—pancreatic cancer	0.00133	0.00632	CcSEcCtD
Pentobarbital—Vomiting—Tamoxifen—pancreatic cancer	0.00132	0.00625	CcSEcCtD
Pentobarbital—Hypotension—Fluorouracil—pancreatic cancer	0.00131	0.00621	CcSEcCtD
Pentobarbital—Hypersensitivity—Sunitinib—pancreatic cancer	0.00131	0.00621	CcSEcCtD
Pentobarbital—Rash—Tamoxifen—pancreatic cancer	0.0013	0.0062	CcSEcCtD
Pentobarbital—Dermatitis—Tamoxifen—pancreatic cancer	0.0013	0.0062	CcSEcCtD
Pentobarbital—Ataxia—Epirubicin—pancreatic cancer	0.0013	0.00619	CcSEcCtD
Pentobarbital—Vomiting—Erlotinib—pancreatic cancer	0.0013	0.00619	CcSEcCtD
Pentobarbital—Somnolence—Irinotecan—pancreatic cancer	0.0013	0.00617	CcSEcCtD
Pentobarbital—Headache—Tamoxifen—pancreatic cancer	0.0013	0.00616	CcSEcCtD
Pentobarbital—Rash—Erlotinib—pancreatic cancer	0.00129	0.00614	CcSEcCtD
Pentobarbital—Dermatitis—Erlotinib—pancreatic cancer	0.00129	0.00613	CcSEcCtD
Pentobarbital—Headache—Erlotinib—pancreatic cancer	0.00128	0.0061	CcSEcCtD
Pentobarbital—Somnolence—Gemcitabine—pancreatic cancer	0.00126	0.00601	CcSEcCtD
Pentobarbital—Constipation—Irinotecan—pancreatic cancer	0.00125	0.00593	CcSEcCtD
Pentobarbital—Somnolence—Fluorouracil—pancreatic cancer	0.00124	0.00591	CcSEcCtD
Pentobarbital—Nausea—Tamoxifen—pancreatic cancer	0.00123	0.00584	CcSEcCtD
Pentobarbital—Constipation—Gemcitabine—pancreatic cancer	0.00122	0.00578	CcSEcCtD
Pentobarbital—Nausea—Erlotinib—pancreatic cancer	0.00122	0.00578	CcSEcCtD
Pentobarbital—Ataxia—Doxorubicin—pancreatic cancer	0.0012	0.00573	CcSEcCtD
Pentobarbital—Feeling abnormal—Irinotecan—pancreatic cancer	0.0012	0.00572	CcSEcCtD
Pentobarbital—Dizziness—Sunitinib—pancreatic cancer	0.00117	0.00557	CcSEcCtD
Pentobarbital—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00117	0.00557	CcSEcCtD
Pentobarbital—Body temperature increased—Irinotecan—pancreatic cancer	0.00115	0.00549	CcSEcCtD
Pentobarbital—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00115	0.00548	CcSEcCtD
Pentobarbital—Vomiting—Sunitinib—pancreatic cancer	0.00113	0.00536	CcSEcCtD
Pentobarbital—Body temperature increased—Gemcitabine—pancreatic cancer	0.00112	0.00534	CcSEcCtD
Pentobarbital—Rash—Sunitinib—pancreatic cancer	0.00112	0.00531	CcSEcCtD
Pentobarbital—Dermatitis—Sunitinib—pancreatic cancer	0.00112	0.00531	CcSEcCtD
Pentobarbital—Headache—Sunitinib—pancreatic cancer	0.00111	0.00528	CcSEcCtD
Pentobarbital—Syncope—Docetaxel—pancreatic cancer	0.00111	0.00527	CcSEcCtD
Pentobarbital—Body temperature increased—Fluorouracil—pancreatic cancer	0.0011	0.00525	CcSEcCtD
Pentobarbital—Loss of consciousness—Docetaxel—pancreatic cancer	0.00109	0.00517	CcSEcCtD
Pentobarbital—Hypersensitivity—Irinotecan—pancreatic cancer	0.00108	0.00511	CcSEcCtD
Pentobarbital—Nausea—Sunitinib—pancreatic cancer	0.00105	0.005	CcSEcCtD
Pentobarbital—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00103	0.0049	CcSEcCtD
Pentobarbital—Confusional state—Docetaxel—pancreatic cancer	0.00102	0.00484	CcSEcCtD
Pentobarbital—Shock—Docetaxel—pancreatic cancer	0.000992	0.00472	CcSEcCtD
Pentobarbital—Bradycardia—Epirubicin—pancreatic cancer	0.000975	0.00464	CcSEcCtD
Pentobarbital—Dizziness—Irinotecan—pancreatic cancer	0.000965	0.00459	CcSEcCtD
Pentobarbital—Hypotension—Docetaxel—pancreatic cancer	0.000943	0.00448	CcSEcCtD
Pentobarbital—Vomiting—Irinotecan—pancreatic cancer	0.000928	0.00441	CcSEcCtD
Pentobarbital—Dizziness—Fluorouracil—pancreatic cancer	0.000924	0.00439	CcSEcCtD
Pentobarbital—Rash—Irinotecan—pancreatic cancer	0.00092	0.00438	CcSEcCtD
Pentobarbital—Dermatitis—Irinotecan—pancreatic cancer	0.000919	0.00437	CcSEcCtD
Pentobarbital—Headache—Irinotecan—pancreatic cancer	0.000914	0.00435	CcSEcCtD
Pentobarbital—Vomiting—Gemcitabine—pancreatic cancer	0.000904	0.0043	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—pancreatic cancer	0.000902	0.00429	CcSEcCtD
Pentobarbital—Somnolence—Docetaxel—pancreatic cancer	0.000897	0.00426	CcSEcCtD
Pentobarbital—Rash—Gemcitabine—pancreatic cancer	0.000896	0.00426	CcSEcCtD
Pentobarbital—Dermatitis—Gemcitabine—pancreatic cancer	0.000895	0.00426	CcSEcCtD
Pentobarbital—Headache—Gemcitabine—pancreatic cancer	0.00089	0.00423	CcSEcCtD
Pentobarbital—Vomiting—Fluorouracil—pancreatic cancer	0.000889	0.00423	CcSEcCtD
Pentobarbital—Rash—Fluorouracil—pancreatic cancer	0.000881	0.00419	CcSEcCtD
Pentobarbital—Dermatitis—Fluorouracil—pancreatic cancer	0.00088	0.00419	CcSEcCtD
Pentobarbital—Headache—Fluorouracil—pancreatic cancer	0.000876	0.00416	CcSEcCtD
Pentobarbital—Nausea—Irinotecan—pancreatic cancer	0.000867	0.00412	CcSEcCtD
Pentobarbital—Constipation—Docetaxel—pancreatic cancer	0.000863	0.0041	CcSEcCtD
Pentobarbital—Nausea—Gemcitabine—pancreatic cancer	0.000844	0.00401	CcSEcCtD
Pentobarbital—Feeling abnormal—Docetaxel—pancreatic cancer	0.000831	0.00395	CcSEcCtD
Pentobarbital—Nausea—Fluorouracil—pancreatic cancer	0.00083	0.00395	CcSEcCtD
Pentobarbital—Tension—Epirubicin—pancreatic cancer	0.000818	0.00389	CcSEcCtD
Pentobarbital—Nervousness—Epirubicin—pancreatic cancer	0.00081	0.00385	CcSEcCtD
Pentobarbital—Body temperature increased—Docetaxel—pancreatic cancer	0.000797	0.00379	CcSEcCtD
Pentobarbital—Agitation—Epirubicin—pancreatic cancer	0.000766	0.00364	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—pancreatic cancer	0.000757	0.0036	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—pancreatic cancer	0.000749	0.00356	CcSEcCtD
Pentobarbital—Syncope—Epirubicin—pancreatic cancer	0.000748	0.00356	CcSEcCtD
Pentobarbital—Hypersensitivity—Docetaxel—pancreatic cancer	0.000743	0.00353	CcSEcCtD
Pentobarbital—Loss of consciousness—Epirubicin—pancreatic cancer	0.000733	0.00348	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—pancreatic cancer	0.000709	0.00337	CcSEcCtD
Pentobarbital—Anxiety—Epirubicin—pancreatic cancer	0.000707	0.00336	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—pancreatic cancer	0.000692	0.00329	CcSEcCtD
Pentobarbital—Confusional state—Epirubicin—pancreatic cancer	0.000686	0.00326	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000678	0.00322	CcSEcCtD
Pentobarbital—Shock—Epirubicin—pancreatic cancer	0.000669	0.00318	CcSEcCtD
Pentobarbital—Dizziness—Docetaxel—pancreatic cancer	0.000667	0.00317	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—pancreatic cancer	0.000654	0.00311	CcSEcCtD
Pentobarbital—Vomiting—Docetaxel—pancreatic cancer	0.000641	0.00305	CcSEcCtD
Pentobarbital—Rash—Docetaxel—pancreatic cancer	0.000636	0.00302	CcSEcCtD
Pentobarbital—Hypotension—Epirubicin—pancreatic cancer	0.000636	0.00302	CcSEcCtD
Pentobarbital—Dermatitis—Docetaxel—pancreatic cancer	0.000635	0.00302	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—pancreatic cancer	0.000635	0.00302	CcSEcCtD
Pentobarbital—Headache—Docetaxel—pancreatic cancer	0.000632	0.00301	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—pancreatic cancer	0.000619	0.00295	CcSEcCtD
Pentobarbital—Somnolence—Epirubicin—pancreatic cancer	0.000605	0.00288	CcSEcCtD
Pentobarbital—Nausea—Docetaxel—pancreatic cancer	0.000599	0.00285	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—pancreatic cancer	0.000588	0.0028	CcSEcCtD
Pentobarbital—Constipation—Epirubicin—pancreatic cancer	0.000582	0.00277	CcSEcCtD
Pentobarbital—Feeling abnormal—Epirubicin—pancreatic cancer	0.000561	0.00267	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—pancreatic cancer	0.00056	0.00266	CcSEcCtD
Pentobarbital—Constipation—Doxorubicin—pancreatic cancer	0.000538	0.00256	CcSEcCtD
Pentobarbital—Body temperature increased—Epirubicin—pancreatic cancer	0.000538	0.00256	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000519	0.00247	CcSEcCtD
Pentobarbital—Hypersensitivity—Epirubicin—pancreatic cancer	0.000501	0.00238	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—pancreatic cancer	0.000498	0.00237	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000464	0.00221	CcSEcCtD
Pentobarbital—Dizziness—Epirubicin—pancreatic cancer	0.00045	0.00214	CcSEcCtD
Pentobarbital—Vomiting—Epirubicin—pancreatic cancer	0.000433	0.00206	CcSEcCtD
Pentobarbital—Rash—Epirubicin—pancreatic cancer	0.000429	0.00204	CcSEcCtD
Pentobarbital—Dermatitis—Epirubicin—pancreatic cancer	0.000429	0.00204	CcSEcCtD
Pentobarbital—Headache—Epirubicin—pancreatic cancer	0.000426	0.00203	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—pancreatic cancer	0.000416	0.00198	CcSEcCtD
Pentobarbital—Nausea—Epirubicin—pancreatic cancer	0.000404	0.00192	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—pancreatic cancer	0.0004	0.0019	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—pancreatic cancer	0.000397	0.00189	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—pancreatic cancer	0.000397	0.00189	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—pancreatic cancer	0.000394	0.00188	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—pancreatic cancer	0.000374	0.00178	CcSEcCtD
